CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Steris Plc  (NYSE: STE)
Other Ticker:  
 
 

STE's Capital Expenditures Growth by Quarter and Year

Steris Plc's Capital Expenditures results by quarter and year

 



STE Capital Expenditures (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter March 70.89 91.50 71.45 50.69
3rd Quarter December 89.23 118.94 91.82 34.82
2nd Quarter September 101.89 83.29 82.77 27.73
1st Quarter June 108.08 66.60 115.93 51.95
FY   370.09 360.33 361.97 165.19





STE Capital Expenditures fourth quarter 2025 Y/Y Growth Comment
Steris Plc reported decline in Capital Expenditures in the fourth quarter 2025 by -22.53% to $ 70.89 millions, from the same quarter in 2024.
The contraction in the fourth quarter 2025 Steris Plc's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures rise of 23.99%.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 37 other companies have achieved higher Capital Expenditures growth. While Steris Plc' s Capital Expenditures fall of -22.53% ranks overall at the positon no. 969 in the fourth quarter 2025.


STE Capital Expenditures ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter March -22.53 % 28.06 % 40.95 % 33.08 %
3rd Quarter December -24.98 % 29.54 % 163.7 % -10.56 %
2nd Quarter September 22.33 % 0.63 % 198.49 % -24.01 %
1st Quarter June 62.28 % -42.55 % 123.16 % -14.39 %
FY   2.71 % -0.45 % 119.12 % -5.17 %

Financial Statements
Steris Plc's fourth quarter 2025 Capital Expenditures $ 70.89 millions STE's Income Statement
Steris Plc's fourth quarter 2024 Capital Expenditures $ 91.50 millions Quarterly STE's Income Statement


STE Capital Expenditures (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter March -20.56 % -23.07 % -22.18 % 45.58 %
3rd Quarter December -12.43 % 42.8 % 10.93 % 25.57 %
2nd Quarter September -5.73 % 25.06 % -28.6 % -46.62 %
1st Quarter June 18.12 % -6.79 % 128.7 % 36.39 %
FY (Year on Year)   2.71 % -0.45 % 119.12 % -5.17 %


Suppliers by STE Divisions >> Back to STE Growth rate Comparisons >>


Capital Expenditures fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #114
Overall #969

Capital Expenditures Y/Y Growth Statistics
High Average Low
123.62 % 23.99 % -12.54 %
(Dec 31 2022)   (Sep 30 2018)
Capital Expenditures fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #114
Overall #969
Capital Expenditures Y/Y Growth Statistics
High Average Low
123.62 % 23.99 % -12.54 %
(Dec 31 2022)   (Sep 30 2018)

Capital Expenditures by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Steris Plc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
157.09 % -2.7 % -100 %
(Dec 31 2015)  


STE's IV. Quarter Q/Q Capital Expenditures Comment
In the IV. Quarter 2025 Steris Plc reported fall in Capital Expenditures sequentially by -20.56% to $ 70.89 millions, from $ 89.23 millions released a quarter before.

But that's not important concern, as Steris Plc's Capital Expenditures frequently gravitate to dip in this quarter.

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Steris Plc's Capital Expenditures growth quarter on quarter, overall rank is 1578.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #270
Overall #1578
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #270
Overall #1578
Capital Expenditures Q/Q Growth Statistics
High Average Low
157.09 % -2.7 % -100 %
(Dec 31 2015)  


STE's IV. Quarter Q/Q Capital Expenditures Comment
In the IV. Quarter 2025 Steris Plc reported fall in Capital Expenditures from the third quarter by -20.56% to $ 70.89 millions, from $ 89.23 millions released a quarter before.

When you evaluate recent slump at the IV. Quarter, you must take into consideration, that commonly IV. Quarter performance appear to be weaker relative to the quarter before

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Steris Plc's Capital Expenditures growth quarter on quarter, overall rank is 1578.


Steris Plc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Capital Expenditures 12 Months Ending $ 370.09 $ 390.70 $ 420.41 $ 376.91 $ 360.33
Y / Y Capital Expenditures Growth (TTM) 2.71 % 14.82 % 34.25 % 4.13 % -0.45 %
Year on Year Capital Expenditures Growth Overall Ranking # 1128 # 615 # 411 # 68 # 0
Seqeuential Capital Expenditures Change (TTM) -5.28 % -7.07 % 4.63 % 10.77 % 5.89 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 969 # 462 # 1243 # 586 # 0


Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Mar 31 2025 period, Steris Plc's cumulative twelve months Capital Expenditures were $ 370 millions, company would post below average annual Capital Expenditures growth of 5.89% year on year, if the fiscal year would end at Mar 31 2025.
A slow-down in the Steris Plc's Capital Expenditures growth from the 89.23% growth in Dec 31 2024.

In the Healthcare sector 132 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 615 to 1128.

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 133
Overall # 1128

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
123.62 %
 23.99 %
-12.54 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 114
S&P 500 # 969
Cumulative Capital Expenditures growth Comment
With the quarterly Capital Expenditures reported in the Mar 31 2025 period, Steris Plc's cumulative twelve months Capital Expenditures were $ 370 millions, company would post below average annual Capital Expenditures growth of -12.54% year on year, if the fiscal year would end at Mar 31 2025.
A slow-down in the Steris Plc's Capital Expenditures growth from the 89.23% growth in Dec 31 2024.

In the Healthcare sector 132 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 615 to 1128.


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 133
Overall # 1128

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
123.62 %
23.99 %
-12.54 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 114
S&P 500 # 969




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
STE's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for STE's Competitors
Capital Expenditures Growth for Steris Plc's Suppliers
Capital Expenditures Growth for STE's Customers

You may also want to know
STE's Annual Growth Rates STE's Profitability Ratios STE's Asset Turnover Ratio STE's Dividend Growth
STE's Roe STE's Valuation Ratios STE's Financial Strength Ratios STE's Dividend Payout Ratio
STE's Roa STE's Inventory Turnover Ratio STE's Growth Rates STE's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2025
Select Medical Holdings Corp-0.34%$ -0.339 millions
Si bone inc -0.48%$ -0.480 millions
Vaxart Inc -0.76%$ -0.763 millions
Idexx Laboratories Inc-0.82%$ -0.816 millions
Gilead Sciences Inc -0.95%$ -0.952 millions
Johnson and Johnson-1.49%$ -1.487 millions
Iqvia Holdings Inc -2.07%$ -2.069 millions
Cadre Holdings inc -2.53%$ -2.532 millions
Myriad Genetics Inc -3.49%$ -3.488 millions
Irhythm Technologies Inc -3.65%$ -3.652 millions
Becton Dickinson And Company-3.73%$ -3.731 millions
Msa Safety Inc-3.88%$ -3.877 millions
Neurocrine Biosciences Inc -4.46%$ -4.464 millions
Vaxcyte Inc -4.47%$ -4.473 millions
Harvard Bioscience Inc -5.14%$ -5.139 millions
Procept Biorobotics Corporation-5.65%$ -5.653 millions
Labcorp Holdings Inc -5.83%$ -5.830 millions
Crinetics Pharmaceuticals Inc -6.98%$ -6.982 millions
Maravai Lifesciences Holdings Inc -7.59%$ -7.590 millions
Amneal Pharmaceuticals Inc -8.13%$ -8.128 millions
Bristol myers Squibb Company-8.45%$ -8.451 millions
Community Health Systems Inc -8.60%$ -8.602 millions
Organon and Co -9.38%$ -9.375 millions
Treace Medical Concepts Inc -9.78%$ -9.778 millions
Novocure Limited-9.95%$ -9.954 millions
Icu Medical Inc-10.68%$ -10.684 millions
Carlisle Companies Incorporated-10.77%$ -10.769 millions
Teladoc Health Inc -11.06%$ -11.058 millions
Immunitybio inc -11.10%$ -11.102 millions
Illumina Inc -11.11%$ -11.111 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com